Who Sets the Global Health Research Agenda? The Challenge of Multi-Bi Financing
article has not abstract
Vyšlo v časopise:
Who Sets the Global Health Research Agenda? The Challenge of Multi-Bi Financing. PLoS Med 9(9): e32767. doi:10.1371/journal.pmed.1001312
Kategorie:
Essay
prolekare.web.journal.doi_sk:
https://doi.org/10.1371/journal.pmed.1001312
Souhrn
article has not abstract
Zdroje
1. Global Economic Governance Programme (2008) High-level working group of developing country health ministers, meeting report. Available: http://www.globaleconomicgovernance.org/wp-content/uploads/Working%20Group%20Report%20May%202008.pdf. Accessed 31 January 2011.
2. Institute for Health Metrics and Evaluation (2011) Financing global health. Available: http://www.healthmetricsandevaluation.org/publications/policy-report/financing-global-health-2011-continued-growth-mdg-deadline-approaches. Accessed 15 July 2012.
3. MoonS, BermudezJ, HoenE (2012) Innovation and access to medicines for neglected populations: could a treaty address a broken pharmaceutical R&D system? PLoS Med 9: e1001218 doi:10.1371/journal.pmed.1001218
4. OECD/DAC (2010) 2010 DAC report on multilateral aid. Available: www.oecd.org/dataoecd/23/17/45828572.pdf. Accessed 31 January 2011.
5. WHO (2012) Programme budgets. Geneva: WHO. Available: http://apps.who.int/gb/archive/. Accessed 31 January 2011.
6. World Bank (2012) World Bank HNP lending. Available: http://web.worldbank.org/WBSITE/EXTERNAL/TOPICS/EXTHEALTHNUTRITIONANDPOPULATION/EXTDATASTATISTICSHNP/EXTHNPSTATS/0,,contentMDK:21198454~menuPK:3385617~pagePK:64168445~piPK:64168309~theSitePK:3237118,00.html. Accessed 31 January 31 2011.
7. Vaughan JP, Mogedal S, Kruse SK, Lee K, Walt G, et al.. (1995) Cooperation for health development: extrabudgetary funds in the World Health Organisation. Published by the Governments of Australia, Norway and the United Kingdom. Geneva: WHO.
8. VaughanJP, MogedalS, WaltG, KruseSK, LeeK, et al. (1996) WHO and the effects of extrabudgetary funds: is the Organization donor driven? Health Policy Plan 16: 253–264.
9. VaughanJP, MogedalS, Stein-ErikK, LeeK, WaltG, et al. (1996) Financing the World Health Organization: global importance of extra-budgetary funds. Health Policy 35: 229–245.
10. StucklerD, KingL, RobinsonH, McKeeM (2008) WHO's budgetary allocations and burden of disease: a comparative analysis. Lancet 372: 1563–1569.
11. The World Bank Group (2008) Partnership & trust fund annual report, Washington. Available: http://siteresources.worldbank.org/CFPEXT/Resources/TFAR_2008.pdf. Accessed 14 August 2012.
12. RøttingenJ-A, ChamasC (2012) A new deal for global health R&D? The recommendations of the Consultative Expert Working Group on Research and Development (CEWG). PLoS Med 9: e1001219 doi:10.1371/journal.pmed.1001219
13. Woods N (2006) The globalizers. Ithaca (New York): Cornell University Press.
14. GodleeF (2004) The World Health Organization: WHO in crisis. BMJ 309: 1424.
15. Global Fund (2012) Grant portfolio. Available: http://portfolio.theglobalfund.org/en/DataDownloads/Index/. Accessed 31 January 31 2011.
16. GAVI (2012) Donor contributions and pledges. Available: http://www.gavialliance.org/funding/donor-contributions-pledges/. Accessed 31 January 2011.
Štítky
Interné lekárstvoČlánok vyšiel v časopise
PLOS Medicine
2012 Číslo 9
- Statinová intolerance
- Očkování proti virové hemoragické horečce Ebola experimentální vakcínou rVSVDG-ZEBOV-GP
- Parazitičtí červi v terapii Crohnovy choroby a dalších zánětlivých autoimunitních onemocnění
- Metamizol v liečbe pooperačnej bolesti u detí do 6 rokov veku
- Co dělat při intoleranci statinů?
Najčítanejšie v tomto čísle
- Lipid-Based Nutrient Supplements: How Can They Combat Child Malnutrition?
- Cryptococcal Meningitis Treatment Strategies in Resource-Limited Settings: A Cost-Effectiveness Analysis
- Effect of Statins on Venous Thromboembolic Events: A Meta-analysis of Published and Unpublished Evidence from Randomised Controlled Trials
- The Effect of Adding Ready-to-Use Supplementary Food to a General Food Distribution on Child Nutritional Status and Morbidity: A Cluster-Randomized Controlled Trial